832 related articles for article (PubMed ID: 37229456)
21. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
[TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
[TBL] [Abstract][Full Text] [Related]
23. Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus.
Sánchez-Quintero MJ; Delgado J; Medina-Vera D; Becerra-Muñoz VM; Queipo-Ortuño MI; Estévez M; Plaza-Andrades I; Rodríguez-Capitán J; Sánchez PL; Crespo-Leiro MG; Jiménez-Navarro MF; Pavón-Morón FJ
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364913
[TBL] [Abstract][Full Text] [Related]
24. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
25. Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites.
Wang D; Liu J; Zhou L; Zhang Q; Li M; Xiao X
Front Endocrinol (Lausanne); 2022; 13():905171. PubMed ID: 35909556
[TBL] [Abstract][Full Text] [Related]
26. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
Drapkina OM; Korneeva ON
Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
[TBL] [Abstract][Full Text] [Related]
27. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
Woldeamlak B; Yirdaw K; Biadgo B
Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
[TBL] [Abstract][Full Text] [Related]
28. Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia.
Jia X; Xu W; Zhang L; Li X; Wang R; Wu S
Front Cell Infect Microbiol; 2021; 11():634780. PubMed ID: 34490132
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
Caesar R
Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
[TBL] [Abstract][Full Text] [Related]
31. Gut Microbiota and Complications of Type-2 Diabetes.
Iatcu CO; Steen A; Covasa M
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
33. Microbiome and diabetes: Where are we now?
Vallianou NG; Stratigou T; Tsagarakis S
Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
35. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
36. The Prospect for Type 2 Diabetes Mellitus Combined with Exercise and Synbiotics: A Perspective.
Dewi L; Rosidi A; Noer ER; Ayuningtyas A
Curr Diabetes Rev; 2021; 17(8):e012821190875. PubMed ID: 33511948
[TBL] [Abstract][Full Text] [Related]
37. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
[TBL] [Abstract][Full Text] [Related]
38. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
39. PuRenDan alleviates type 2 diabetes mellitus symptoms by modulating the gut microbiota and its metabolites.
Ma X; Qiu Y; Mao M; Lu B; Zhao H; Pang Z; Li S
J Ethnopharmacol; 2024 Mar; 322():117627. PubMed ID: 38147943
[TBL] [Abstract][Full Text] [Related]
40. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
